{
    "organizations": [],
    "uuid": "48de6e99d1e86b9cd4aca66a780057d7ec2621f9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jiangsu-hengrui-medicine-receives/brief-jiangsu-hengrui-medicine-receives-gmp-certificate-idUSL4N1QI4UL",
    "ord_in_thread": 0,
    "title": "BRIEF-Jiangsu Hengrui Medicine receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Jiangsu Hengrui Medicine Co Ltd :\n* Says it received goods manufacture practice (GMP) certificate from Health and Youth Care Inspectorate\n* Certificate issued iodixanol injection, oxaliplatin for injection and caspofungin acetate for injection as well as Letrozole Tablets manufactured by the company and the valid period is until Sep. 2020\nSource text in Chinese: goo.gl/6tqizF\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-28T18:25:00.000+02:00",
    "crawled": "2018-03-01T20:57:44.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "jiangsu",
        "hengrui",
        "medicine",
        "co",
        "ltd",
        "say",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "health",
        "youth",
        "care",
        "inspectorate",
        "certificate",
        "issued",
        "iodixanol",
        "injection",
        "oxaliplatin",
        "injection",
        "caspofungin",
        "acetate",
        "injection",
        "well",
        "letrozole",
        "tablet",
        "manufactured",
        "company",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}